Philadelphia

Philadelphia, Pennsylvania 19141

1 studies enrolling now · 10 studies all time

What they study most

Cirrhosis, Clostridium Difficile Infection, Clostridium Difficile Infection (CDI), Communicable Diseases, Contraception, Endometriosis, Endometriosis Related Pain, Heart Failure With Preserved Ejection Fraction, Heavy Menstrual Bleeding, Infection, Neurotrophic Keratitis, Non-alcoholic Steatohepatitis

Studies at this site

• A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis — Recruiting now
• A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study) — Running, not enrolling
• Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are at Risk for Pregnancy — Completed
• Study to Evaluate OXERVATE® in Patients With Stage 1 Neurotrophic Keratitis — Completed
• Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCH CD3-OLS) — Completed
• Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3) — Completed
• LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids — Completed
• LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids — Completed
• Emricasan, an Oral Caspase Inhibitor, in Subjects With NASH Cirrhosis and Severe Portal Hypertension — Completed
• SPIRIT 1: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain — Completed